Overview
Status
Active
Registry date
2019-08-20
Share capital
5,000.00 PLN
Registered address
Plac Bankowy 2, 00-095 Warszawa, Poland
Electronic delivery address
AE:PL-50373-26275-TTHCR-29
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 7 days early.
- 202512/07/2026
- 202414/07/2025
- 202313/07/2024
- 202211/07/2023
- 202114/07/2022
- 202014/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 476.11kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 246.15kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 175.74kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 311.88kMedianUSD 609.79kAverageUSD 11.85m
Industry
Public procurement
No recorded participation in tenders.
Malew is the contractor in one public sector contract, worth USD 3.20k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Aug 26, 2026 | Supply of surplus plasma. | $3,202 | Regionalne Centrum Krwiodawstwa I Krwiolecznictwa w Bydgoszczy |
Authorized Representatives
Katarzyna Piotrowicz – Management Board Member
Mieczysław Obszański – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mieczysław Obszańskiage 69 | 51 | $688.82 | 51% |
Katarzyna Piotrowiczage 45 | 49 | $661.80 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-09-06.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 18, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dental Solutionssp. z o.o. | $611,683.37 | dentalsolutions.pl | ||
| Beauty Care Solutionsp. z o.o. | $391,209.94 | ohhira.pl | ||
| Aimedicalsp. z o.o. | $240,059.72 | aimedical.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu |
FAQ
The main business activity of Malew focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on August 20, 2019.
The headquarters is located at: Plac Bankowy 2, 00-095 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $141,795 in 2024, which is an increase of 81.5% compared to 2023.
Yes, the company recorded a net profit of $46,625 in 2024, meaning the company increased its profit by 25.1%.
The largest operating cost category falls under other operating costs. This category amounted to $66,316 in 2024, representing 79% of all operating expenses.
Last updated: 2026-07-16
